March 8, 2018
[vc_row][vc_column][vc_column_text] From its early days as one the first suppliers of animal models for research in 1947, Charles River Laboratories (CRL) has developed into a brand […]
News, research & analysis from the global Biopharmaceutical and related industries.
February 22, 2018
[vc_row][vc_column][vc_column_text] The Novo Nordisk Foundation Centre for Biosustainability recently published an exciting finding that could herald the beginning of utilising bioproduction for the large-scale manufacture of […]
February 20, 2018
[vc_row][vc_column][vc_column_text] The Drug Development IPO market enjoyed a strong year in 2018, with over $10.24B raised by 95 companies across 15 global exchanges. When compared to […]
January 30, 2018
[vc_row][vc_column][vc_column_text]2017 saw a total of 73 Drug Development IPOs across 15 global exchanges, compared to 58 IPOs in 2016. In total approximately $6.4B was raised, 1% […]
January 23, 2018
[vc_row][vc_column][vc_column_text]The Food and Drug Administration recently announced the first ever approval of a directly administered gene therapy in the United States. Spark Therapeutics one-time gene therapy […]
December 8, 2017
October 24, 2017
[vc_row][vc_column][vc_column_text] Philadelphia-based Spark Therapeutics recently received unanimous backing from an FDA advisory panel for Luxturna™, a one-shot gene therapy treatment for biallelic RPE65-mediated inherited retinal dystrophy […]
October 16, 2017
[vc_row][vc_column][vc_column_text] German pharmaceutical company Evotec has expanded its partnership with Scottish artificial intelligence drug design pioneers Exscientia, investing a further €15m in exchange for a minority […]
October 5, 2017
[vc_row][vc_column][vc_column_text] The global therapeutic IPO market has failed to maintain the upward momentum established throughout a busy Q2 2017, with just over $1B raised by 13 […]